Cadence Pharmaceuticals™

Contact Us

Investor Relations contact:
Anna Gralinska
Cadence Pharmaceuticals
(858) 436-1452
ir@cadencepharm.com

Questions for the Investor Relations Department can also be submitted through the form below. Fields marked with an * are required.

 
 
 
 
 
 
This helps Cadence Pharmaceuticals, Inc. prevent automated submissions.
 
Print page Print
Email page Email


Stock Quote
CADX - (NASD)
$9.89   + 0.07
Aug 28, 2008
12:47 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by TurboFeed.

©2005 Cadence™ Pharmaceuticals. All rights reserved. No portion of cadencepharm.com may be duplicated, redistributed or manipulated in any form. CADENCE and OMIGARD are trademarks of Cadence Pharmaceuticals, Inc.